Skip to main content

Estradiol News

Related terms: Estradiol Topical

Long-Term Study of Postmenopausal Women Does Not Support Many Preventive Therapies

THURSDAY, May 2, 2024 – The longitudinal Women's Health Initiative trials do not support hormone therapy for cardiovascular disease prevention, calcium and vitamin D supplementation for universal...

Major Women's Health Study Supports Hormone Replacement Therapy in Early Menopause

WEDNESDAY, May 1, 2024 – Hormone replacement therapy can safely ease middle-aged women’s symptoms during early menopause, data from a major women’s health study show. Women younger than 60 can use ho...

Menopausal Hormone Therapy Use Beyond 65 Years Beneficial

TUESDAY, April 16, 2024 – Use of menopausal hormone therapy beyond age 65 years is associated with risk reductions in mortality as well as specific cancers and cardiovascular diseases, according to...

Treating Vaginal Dryness Around and After Menopause

Wednesday, Feb. 21, 2024 – Postmenopausal or peri-menopausal women are often hampered by vaginal dryness, which can put the brakes on a healthy sex life. It doesn't have to stay that way, experts...

Estrogen Could Be Key to Women's Brain Health

THURSDAY, Sept. 28, 2023 – Being exposed to more estrogen throughout life – or a longer reproductive life span – may be good for the brain, according to new research that found a lower risk of...

Age, Race, Education Most Prevalent Disparities Tied to Menopausal Hormone Therapy Rx

WEDNESDAY, Sept. 27, 2023 – Age, race, and education are the most prevalent disparities associated with menopausal hormone therapy (MHT) prescribing, according to research presented at the annual...

TherapeuticsMD Announces FDA Approval of Imvexxy (estradiol vaginal inserts) for the Treatment of Dyspareunia Due to Menopause

BOCA RATON, Fla., May 30, 2018 /PRNewswire/ – TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative women's healthcare company, today announced that the United States Food and Drug Administration (FDA)...

Noven Receives FDA Approval of a New Indication with a New Dose for Minivelle

Miami, FL and New York, NY, – September 24, 2014 – Noven Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved a new indication with a new dose of...

FDA Medwatch Alert: Olympia Pharmacy Sterile Compounded Products: Recall - Concerns About Sterility Assurance

  [Posted 05/30/2013] ISSUE: Lowlite Investments d/b/a Olympia Pharmacy ("Lowlite") notified the public of a voluntary multi-state recall of all sterile drug products compounded by the pharmacy that ...

FDA Approves 10 mcg Dose of Vagifem for the Treatment of Atrophic Vaginitis Due to Menopause

PRINCETON, N.J., Dec. 2 /PRNewswire-FirstCall/ – Novo Nordisk said today that the U.S. Food and Drug Administration (FDA) has approved a 10 mcg dose formulation of Vagifem (estradiol vaginal...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Atrophic Vaginitis, Postmenopausal Symptoms, Overactive Bladder, Prostate Cancer

Related drug support groups

Estrace

Estradiol patient information at Drugs.com